⚡ Live Signal Feed
122 signals · Ranked by priority · Clinical research + community sentiment
Priority = sentiment strength × evidence quality (max 99) · Community signals capped at "Moderate"
122
Total Signals
All sources combined
100
🔬 Clinical/Research
Peer-reviewed + gov sources
22
🗣 Community
Reddit & forum discussions
44
🇺🇸 US Signals
US-sourced intelligence
34
🇨🇦 Canada Signals
Canada-specific coverage
🗣
Community Signals (Reddit)Sourced from r/Testosterone, r/TRT, r/malementalhealth, r/AskMen, r/Supplements, r/longevity · Not peer-reviewed · Reflects real patient experiences · Always capped at "Moderate" strength
8 Signals · Sorted by Priority80–99 = high impact · 60–79 = notable · below = monitoring
🇺🇸 US⚡ Testosterone↑ PositiveModerate
NIH research reviewing 103 men post-radical prostatectomy found TRT does not appear to increase cancer recurrence. This provides reassurance for hypogonadal men with treated prostate cancer.
91
Priority
High
🗣 Community⚡ Testosterone↑ PositiveModeratecommunity data
Men with 4-10+ years on TRT consistently describe transformative improvements in body composition, energy, and quality of life. This positive sentiment from experienced users may influence newer patients considering long-term commitment to therapy.
90
Priority
Social
🗣 Community⚡ Testosterone↓ Risk SignalModeratecommunity data
Men express concern about testicular shutdown and dependency, worrying about scenarios where they lose insurance, jobs, or access to medication. This fear of being 'trapped' on therapy creates hesitation even among symptomatic men.
82
Priority
Social
🗣 Community⚡ Testosterone↓ Risk SignalModeratecommunity data
Newer TRT users report struggling with dialing in dosages, with high estrogen side effects at higher doses causing regret and second-guessing. The trial-and-error process in the first months creates negative experiences that may lead to dropout.
80
Priority
Social
🇺🇸 US⚡ Testosterone↓ Risk SignalModerate
Public Citizen formally requested the FDA restore boxed warnings for cardiovascular risks on testosterone products and halt expanded indications without independent studies. This reflects ongoing safety concerns among consumer health advocates.
80
Priority
Notable
🇺🇸 US⚡ Testosterone↓ Risk SignalModerate
US Pharmacist reports significant interest in TRT among younger men, with 14% having used testosterone products. This demonstrates growing demand that may outpace evidence-based clinical indications.
76
Priority
Notable
🇺🇸 US⚡ TestosteronePeer-Reviewed
On December 10, 2025, the FDA hosted leading experts to evaluate testosterone therapy evidence and potential regulatory changes. This signals possible tightening of TRT oversight in the US market.
69
Priority
Monitor
🗣 Community⚡ TestosteroneModeratecommunity data
Men in their early 30s with below-range testosterone are turning to Reddit communities for reassurance and real-world experiences before medical consultations, indicating distrust or uncertainty about clinical guidance alone.
63
Priority
Social